We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
37 hedge funds and large institutions have $57.9M invested in Fate Therapeutics in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
67.73% more ownership
Funds ownership: 0% → 67.73% (+68%)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $60.8M → $57.9M (-$2.9M)
8% less funds holding
Funds holding: 40 → 37 (-3)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
12
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$10.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$2.01M |
| 3 |
Morgan Stanley
New York
|
+$1.49M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$226K |
| 5 |
Renaissance Technologies
New York
|
+$58.6K |
